Person

Daniel J. Levangie

Formerly EVP & President, Drug Delivery, Insulet Corporation

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$619K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 10, 2016PODDSale4,699$30.65$144K
Mar 9, 2016PODDSale7,600$31.04$236K
Mar 7, 2016PODDSale7,663$31.15$239K

SEC reporting-owner ID (CIK) 1187406 · all filings on EDGAR

Daniel J. Levangie | USBoard